BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27133918)

  • 21. Environmental and Psychosocial Barriers to and Benefits of Cervical Cancer Screening in Kenya.
    Buchanan Lunsford N; Ragan K; Lee Smith J; Saraiya M; Aketch M
    Oncologist; 2017 Feb; 22(2):173-181. PubMed ID: 28167567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cues to Cervical Cancer Screening Among U.S. Hispanic Women.
    Moore de Peralta A; Holaday B; Hadoto IM
    Hisp Health Care Int; 2017 Mar; 15(1):5-12. PubMed ID: 28558513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controversies about cervical cancer screening: A qualitative study of Roma women's (non)participation in cervical cancer screening in Romania.
    Andreassen T; Weiderpass E; Nicula F; Suteu O; Itu A; Bumbu M; Tincu A; Ursin G; Moen K
    Soc Sci Med; 2017 Jun; 183():48-55. PubMed ID: 28460211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Women's autonomy and cervical cancer screening in the Lesotho Demographic and Health Survey 2009.
    Viens LJ; Clouston S; Messina CR
    Soc Sci Med; 2016 Feb; 150():23-30. PubMed ID: 26722985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Women's Awareness of and Responses to Messages About Breast Cancer Overdiagnosis and Overtreatment: Results From a 2016 National Survey.
    Nagler RH; Franklin Fowler E; Gollust SE
    Med Care; 2017 Oct; 55(10):879-885. PubMed ID: 28857962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing Cervical Cancer Awareness and Screening in Jamaica: Effectiveness of a Theory-Based Educational Intervention.
    Coronado Interis E; Anakwenze CP; Aung M; Jolly PE
    Int J Environ Res Public Health; 2015 Dec; 13(1):ijerph13010053. PubMed ID: 26703641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eliciting women's cervical screening preferences: a mixed methods systematic review protocol.
    Wood B; Van Katwyk SR; El-Khatib Z; McFaul S; Taljaard M; Wright E; Graham ID; Little J
    Syst Rev; 2016 Aug; 5(1):136. PubMed ID: 27516072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
    Soccio J; Brown M; Comino E; Friesen E
    J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited Understanding of Pap Smear Testing among Women, a Barrier to Cervical Cancer Screening in the United Arab Emirates.
    AL-Hammadi FA; Al-Tahri F; Al-Ali A; Nair SC; Abdulrahman M
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3379-3387. PubMed ID: 29286607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of the disease label 'polycystic ovary syndrome' on intention to have an ultrasound and psychosocial outcomes: a randomised online study in young women.
    Copp T; McCaffery K; Azizi L; Doust J; Mol BWJ; Jansen J
    Hum Reprod; 2017 Apr; 32(4):876-884. PubMed ID: 28333180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing perceived clarity of information on overdiagnosis used for breast and prostate cancer screening in England: an experimental survey.
    Ghanouni A; Renzi C; McBride E; Waller J
    BMJ Open; 2017 Aug; 7(8):e015955. PubMed ID: 28827249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung cancer screening overdiagnosis: reports of overdiagnosis in screening for lung cancer are grossly exaggerated.
    Mortani Barbosa EJ
    Acad Radiol; 2015 Aug; 22(8):976-82. PubMed ID: 25772581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada.
    Vahabi M; Lofters A
    BMC Public Health; 2016 Aug; 16(1):868. PubMed ID: 27557928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Overdiagnosis in mammography screening for breast cancer].
    Huang YB; Yang L; Song FJ; Chen KX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Nov; 38(11):1574-1578. PubMed ID: 29141352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dense breast tissue notification: impact on women's perceived risk, anxiety, and intentions for future breast cancer screening.
    Yeh VM; Schnur JB; Margolies L; Montgomery GH
    J Am Coll Radiol; 2015 Mar; 12(3):261-6. PubMed ID: 25556313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysing the ethics of breast cancer overdiagnosis: a pathogenic vulnerability.
    Rogers WA
    Med Health Care Philos; 2019 Mar; 22(1):129-140. PubMed ID: 30030748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using the Theory of Planned Behavior to Understand Cervical Cancer Screening Among Latinas.
    Roncancio AM; Ward KK; Sanchez IA; Cano MA; Byrd TL; Vernon SW; Fernandez-Esquer ME; Fernandez ME
    Health Educ Behav; 2015 Oct; 42(5):621-6. PubMed ID: 25712240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Motivators for women to attend cervical screening: the influential role of GPs.
    O'Connor M; Murphy J; Martin C; O'Leary J; Sharp L;
    Fam Pract; 2014 Aug; 31(4):475-82. PubMed ID: 24927724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Influence of Absolute and Comparative Risk Perceptions on Cervical Cancer Screening and the Mediating Role of Cancer Worry.
    Zhao X; Nan X
    J Health Commun; 2016; 21(1):100-8. PubMed ID: 26312444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.
    Augusto EF; Rosa ML; Cavalcanti SM; Oliveira LH
    Arch Gynecol Obstet; 2013 Jan; 287(1):53-8. PubMed ID: 22886356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.